Musculoskeletal Adverse Effects Associated with Inhaled Levofloxacin in a Patient with Cystic Fibrosis: A Case Report. (PubMed, Respir Med) - Jun 9, 2026 - "Symptoms occurred exclusively during treatment cycles, resolved upon discontinuation, and have not recurred since cessation. This case highlights a potential association between inhaled levofloxacin and musculoskeletal adverse effects, emphasizing the need for clinician awareness despite the drug's favorable safety profile."
Adverse events • Journal • Cystic Fibrosis • Genetic Disorders • Immunology • Infectious Disease • Musculoskeletal Diseases • Musculoskeletal Pain • Pain • Pulmonary Disease • Respiratory Diseases
|
|
Dejene Shiferaw; Nicki Allsup; Sayed Alwadaei
|